NasdaqGS - Nasdaq Real Time Price USD

LifeStance Health Group, Inc. (LFST)

Time to buy LFST?

5.73

-0.08

(-1.38%)

At close: May 9 at 4:00:00 PM EDT

5.73

0.00

(0.00%)

After hours: May 9 at 4:26:15 PM EDT

Time to buy LFST?

LifeStance Health Group First Quarter 2025 Earnings: EPS: US$0.002 (vs US$0.056 loss in 1Q 2024)

LifeStance Health Group ( NASDAQ:LFST ) First Quarter 2025 Results Key Financial Results Revenue: US$333.0m (up 11...

Simply Wall St. 2 days ago

LFST
-1.38%
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why

LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks 3 days ago

LFST
-1.38%
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround

LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks 3 days ago

LFST
-1.38%
LifeStance Health Group Inc (LFST) Q1 2025 Earnings Call Highlights: A Promising Start with ...

LifeStance Health Group Inc (LFST) reports robust growth in revenue and clinician numbers, achieving its first positive net income as a public company amidst a challenging economic landscape.

GuruFocus.com 3 days ago

LFST
-1.38%
LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1

LifeStance Health (LFST) delivered earnings and revenue surprises of 100% and 0.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 days ago

LFST
-1.38%

DVA
LifeStance Health Group’s (NASDAQ:LFST) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations

Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.8% year on year to $333 million. On the other hand, next quarter’s revenue guidance of $342 million was less impressive, coming in 2.7% below analysts’ estimates. Its GAAP loss of $0 per share was significantly above analysts’ consensus estimates.

StockStory 4 days ago

LFST
-1.38%
LifeStance Reports First Quarter 2025 Results

SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025. (All results compared to prior-year comparative period, unless otherwise noted)Q1 2025 Highlights and FY 2025 Outlook Revenue of $333.0 million increased 11% compared to revenue of $300.4 millionClinician base increased 10% to 7,535 clinicians, a sequen

GlobeNewswire 4 days ago

LFST
-1.38%
LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect

Behavioral health company LifeStance Health (NASDAQ:LFST) will be reporting earnings tomorrow before the bell. Here’s what you need to know.

StockStory 5 days ago

LFST
-1.38%

EHC
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade

The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 6 days ago

LFST
-1.38%
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 11 days ago

LFST
-1.38%
3 Promising Growth Companies With Up To 15% Insider Ownership

Over the last 7 days, the United States market has risen by 5.2%, contributing to a 9.9% increase over the past 12 months, with earnings forecasted to grow by 14% annually. In this environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its future prospects.

Simply Wall St. 11 days ago

KINS

MAX

LFST
-1.38%
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

StockStory 12 days ago

LFST
-1.38%

SUPN

ASGN
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internat

GlobeNewswire 19 days ago

LFST
-1.38%
RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth. Trump's comments added pressure to an already sensitive market, raising concerns about political interference in monetary policy.

StockStory 19 days ago

RXO

SGRY

LFST
-1.38%
3 Healthcare Stocks with Questionable Fundamentals

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 15.5%. This drop was worse than the S&P 500’s 10% fall.

StockStory 23 days ago

LFST
-1.38%

GDRX

DGX
Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Encompass Health (NYSE:EHC) and its peers.

StockStory 23 days ago

EHC

LFST
-1.38%

SGRY
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks, starting with Select Medical (NYSE:SEM).

StockStory 24 days ago

SEM

LFST
-1.38%

SGRY
3 Reasons LFST is Risky and 1 Stock to Buy Instead

LifeStance Health Group trades at $6.79 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 7.1% while the S&P 500 is down 8.3%. This may have investors wondering how to approach the situation.

StockStory 25 days ago

LFST
-1.38%
LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions

A LifeStance Health survey released today reveals the profound impact of social media on Americans' mental health and relationships, stemming from the prevalence of an "always-on" connectivity culture and a growing reliance on online mental health content, despite concerns about misinformation and credibility.

PR Newswire 26 days ago

LFST
-1.38%
Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains?

Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks last month

ADUS

LFST
-1.38%

Performance Overview

Return	LFST	S&P 500 (^GSPC)
YTD	-22.25%	-3.77%
1-Year	-19.52%	+8.55%
3-Year	-7.58%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

LifeStance Health Group, Inc. (LFST)

LifeStance Health Group First Quarter 2025 Earnings: EPS: US$0.002 (vs US$0.056 loss in 1Q 2024)

LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why

Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround

LifeStance Health Group Inc (LFST) Q1 2025 Earnings Call Highlights: A Promising Start with ...

LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1

LifeStance Health Group’s (NASDAQ:LFST) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations

LifeStance Reports First Quarter 2025 Results

LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect

Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade

LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

3 Promising Growth Companies With Up To 15% Insider Ownership

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

3 Healthcare Stocks with Questionable Fundamentals

Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest

Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest

3 Reasons LFST is Risky and 1 Stock to Buy Instead

LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions

Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains?

Performance Overview